PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | C0023895|liver disease |
| Sentences | 65 |
| PubMedID- 22235243 | Patients were excluded if they had active hiv-related opportunistic infection, cancer, hepatitis b coinfection, other causes of liver disease, hemoglobinopathies, previous history of severe psychiatric illness, autoimmune diseases, abnormal renal function, or pregnancy. |
| PubMedID- 22798114 | Methods: the study enrolled 94 chronic hepatitis b patients with compensated liver disease. |
| PubMedID- 23637498 | The present study was designed to investigate the distribution of genotypes and its association with severity of liver disease in patients with chronic hepatitis b (chb) in uttar pradesh, india. |
| PubMedID- 26357604 | Especially noticeable is the rapid decline by 47% from 1999 to 2006 of incidence rate of waiting list registration for end stage liver disease due to hepatitis b compared to that due to hepatitis c or non-viral liver disease.46 the temporal correlation of the trend and the availability of anti-hbv nucleos(t)ides, starting with use of lam in 1998, suggests that broad application of these medications, in part, contributed to the decreased incidence of decompensated chb disease. |
| PubMedID- 21415769 | Background: hepatitis b leads to chronic liver disease, cirrhosis, and hepatocellular cancer. |
| PubMedID- 22141390 | Entecavir: a review of its use in the treatment of chronic hepatitis b in patients with decompensated liver disease. |
| PubMedID- 22087108 | It can cause cryptogenic liver disease, acute exacerbation of chronic hepatitis b, or even fulminant hepatitis and development of hepatocellular carcinoma . |
| PubMedID- 23801844 | Aim: to evaluate psychometrics of the chinese (mainland) chronic liver disease questionnaire (cldq) in patients with chronic hepatitis b (chb). |
| PubMedID- 21789263 | The incidence of hepatocellular carcinoma (hcc) has risen as a result of increased global burden of chronic liver disease due to hepatitis b and c virus infections, aflatoxin b1, alcoholism, and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis associated with the metabolic syndrome. |
| PubMedID- 24651854 | Importantly, similar m2-like macrophage accumulation was confirmed in chronic hepatitis b patients with liver diseases. |
| PubMedID- 22308138 | Of late, liver diseases due to chronic hepatitis b and c infection are becoming a leading cause of death and decrease life expectancy among persons with hiv infections worldwide 1. |
| PubMedID- 21152178 | Combined chronic hepatitis b and c leads to more severe liver disease and an increased risk of hcv . |
| PubMedID- 26294919 | Initial findings revealed that human bm-mscs were able to improve liver function in hepatitis b patients with end-stage liver disease . |
| PubMedID- 20154579 | Introduction: since the advent of haart, liver-related mortality has become the leading cause of non-aids deaths in hiv-infected patients in western countries, complications of end-stage liver disease due to chronic hepatitis b, chronic hepatitis c or both being mainly responsible. |
| PubMedID- 24665160 | The study evaluated the frequency of hepatitis b and c in patients with chronic liver disease and correlated the levels of serum alpha-fetoprotein with hepatitis b and c infection in the patients. |
| PubMedID- 25874508 | Occult hepatitis b infection in children with chronic liver disease. |
| PubMedID- 23438451 | There is a strong association among diet induced obesity, fatty liver disease and development of nonalcoholic steatohepatitis but the environmental link to disease progression remains unclear. |
| PubMedID- 26357642 | Selected mirna biomarkers from patients with hbv infection, patients with skeletal muscle disease, and healthy subjects.113 they showed that increased serum mir-122 levels correlated with histopathologic alterations and appeared earlier compared with alanine aminotransferase (alt) levels, which remained within the reference intervals.113 also, increased serum mirna-122 levels were more specific for liver injury than for other organ damage.113 other studies showed that serum mir-122 may allow for discrimination of hcc patients from healthy subjects but was not useful for distinguishing hcc cases from hbv carriers.114,115 serum mir-223 together with mir-125b-5p have been reported as promising biomarkers of very early hbv-positive hcc, even in advanced stages of liver disease due to chronic hepatitis b.116 other mirnas have been suggested to have great diagnostic value. |
| PubMedID- 23252849 | Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis b virus subgenotype d1 prevalent in turkey. |
| PubMedID- 23469281 | Still, certain co-infections and -morbidities such as liver disease due to viral hepatitis b and c infection cause considerable morbidity and mortality: data from the d:a:d cohort demonstrated liver-related complications to be the leading cause of non-aids related deaths of patients under cart in europe, the usa and australia in 2006 3. |
| PubMedID- 23622604 | There is an extremely high burden of liver disease owing to viral hepatitis b (hbv); about 2 billion people are infected and 350 million are chronic carriers of hbv worldwide. |
| PubMedID- 26045709 | Saturated fatty acid inhibits viral replication in chronic hepatitis b virus infection with nonalcoholic fatty liver disease by toll-like receptor 4-mediated innate immune response. |
| PubMedID- 23722669 | Patients with hcv infection at presentation were included, but patients with complications such as underlying lymphoproliferative disorders, autoimmune diseases like lupus nephritis, infection, and liver disease due to hepatitis b virus or alcohol abuse were excluded. |
| PubMedID- 22012714 | The virologic determinants of progressive liver disease associated with hepatitis b virus (hbv) remain unclear. |
| PubMedID- 25208465 | liver diseases were mostly attributed to hepatitis b virus infection (32%). |
| PubMedID- 21254162 | Data are limited on the safety and effectiveness of oral antivirals other than lamivudine and adefovir dipivoxil for treatment of chronic hepatitis b (chb) in patients with decompensated liver disease. |
| PubMedID- 20461127 | , francetwo double-blind, placebo controlled trials to investigate the safety and tolerability of two dosing regimens of adv (10 mg daily or 30 mg daily), 48-wk follow-up.n = 515 in the 10-mg study and 185 in the 30-mg study, chronic hepatitis b patients with compensated liver disease not undergoing treatment with evidence of viral replication.no overall median change from baseline in serum creatinine or phosphorus levels in 10 mg group. |
| PubMedID- 23146778 | All articles that provided enough information to estimate the chronic liver disease risk associated with occult hepatitis b virus infection were selected. |
| PubMedID- 25578311 | Platelets are key elements in the pathogenesis of acute and chronic liver disease associated with hepatitis b virus (hbv) infection by promoting the accumulation of virus-specific cd8(+) t cells and nonspecific inflammatory cells into the liver parenchyma. |
| PubMedID- 26226455 | liver disease associated with persistent hepatitis b virus (hbv) infection represents a major health problem with global impact. |
| PubMedID- 24622763 | Most patients had underlying liver disease due to hepatitis b or c virus infection or preoperative chemotherapy: 26 patients (33.8 %) had chronic hepatitis, 20 (26.3 %) had liver cirrhosis, and 23 (30.3 %) had received preoperative chemotherapy. |
| PubMedID- 26112990 | Interactions of hepatitis b virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact. |
| PubMedID- 24742346 | Infection with hepatitis a virus (hav) in patient with chronic liver disease (cld; due to hepatitis b or hepatitis c) may cause severe disease and fulminant liver failure. |
| PubMedID- 26300933 | hepatitis b can lead to serious liver diseases, including cirrhosis, liver cancer. |
| PubMedID- 25923596 | Background: one of the more clinically relevant co-morbidities in hiv-infected patients is the development of progressive liver disease due to hepatitis b virus (hbv) or hepatitis c virus (hcv). |
| PubMedID- 23923056 | Superinfection with hepatitis a virus (hav) or hepatitis b virus (hbv) in patients with underlying chronic liver disease is associated with a higher risk of morbidity and mortality , 5. |
| PubMedID- 25759633 | Secondary or acquired iron overload state, in the absence of an abnormal gene, suggests disorders such as chronic hemolytic anemias, dysmetabolic hyperferritinemia, chronic liver disease due to alcohol, hepatitis b or c, porphyria cutanea tarda and iatrogenic iron overload conditions. |
| PubMedID- 23760378 | Thus, the current study findings do not indicate the contribution of occult hepatitis b infection as the cause of chronic liver disease in the patients studied. |
| PubMedID- 26384610 | To determine the threshold value for identifying chronic liver disease, 29 patients with chronic hepatitis b who underwent liver biopsy, including patients without fibrosis (fibrosis stage f0; n = 9) and patients with substantial fibrosis (f1-f2; n = 20) were also investigated. |
| PubMedID- 23626552 | In older patients, common predisposing conditions include cirrhosis in general, and in particular chronic liver disease associated with persistent hepatitis b and c infection. |
| PubMedID- 22681852 | Although several chronic liver diseases are associated with hcc, hepatitis b virus (hbv) and hepatitis c virus (hcv) statistically are the most commonly implicated risk factors. |
| PubMedID- 23551989 | The association between circulating oestradiol levels and severity of liver disease in males with hepatitis b virus infection. |
| PubMedID- 22084743 | A 66-year-old man with chronic liver disease due to hepatitis b developed hepatocellular carcinoma for which a right partial hepatectomy was performed. |
| PubMedID- 25596188 | Both recommend providing prep to msm as a component of a comprehensive hiv prevention package, including increased availability of condoms and lubricants, regular hiv testing, sti screening, and art initiation at cd4 counts <500 cells/ml or immediately for specific conditions (i.e., a seronegative partner, active tb disease, hepatitis b virus infection with severe chronic liver disease). |
| PubMedID- 22856889 | The misconception that severe liver disease due to hepatitis b would show symptoms may contribute to unwillingness of patients to take time to attend regular medical follow up, and this would cause deterioration of the disease condition if treatment is delayed. |
| PubMedID- 24768454 | The leading causes of chronic liver disease associated with hcc are hepatitis b and c viruses throughout the world, and alcohol and nash in france. |
| PubMedID- 25596623 | Additionally, risk factors such as heavy alcohol use or co-infection with hepatitis b may lead to progression of liver disease even in the presence of svr. |
| PubMedID- 26201622 | Nafld seems to be related to host metabolic factors rather than viral factors and does not seem to affect severity of the liver disease in patients with chronic hepatitis b. |
| PubMedID- 24072155 | hepatitis b infection is associated with progressive liver disease and diminished survival in kidney transplant recipients. |
| PubMedID- 24403913 | Measured nine serum fibrosis markers including tissue inhibitor of metalloproteinase 1 (timp-1), tenascin-c, piiinp, laminin, matrix metalloproteinase-2 and 9, collagen type iv, collagen type vi and hyaluronan to predict advanced liver disease in patients with chronic hepatitis b. they observed that levels of timp1 and ha and finally their combination are powerful markers amongst other measured serum fibrosis markers to be used instead of a liver biopsy (10). |
Page: 1 2